Welcome to TaMADOR

Two NIDDK programs, one focused on Type 1 Diabetes and one focused on Obesity, funded research groups with the goal of developing and disseminating targeted mass spectrometry assays for the diagnosis and monitoring of Type 1 Diabetes and Obesity. While the funding sources are separate, we felt there were obvious synergies in these efforts and formed TaMADOR with the goal of leveraging each other's capabilities and strengths.

NIH Funding Announcements

Type 1 Diabetes Assays

University of Washington

Quantifying Proteins in Plasma to Democratize Personalized Medicine for Patients with Type 1 Diabetes

PIs: Andrew Hoofnagle, Michael MacCoss

University of Washington & PNNL

Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications

PIs: Jun Qu, Wei-Jun Qian

Obesity Assays

Cedars-Sinai Medical Center

Design and Validation of Easy-to-Adopt Mass Spectrometry Assays of Importance to Obesity

PI: Jennifer Van Eyk

Pacific Northwest National Laboratory

Multiplex Mass Spectrometric Protein Assays for Precise Monitoring of the Pathophysiology of Obesity

PI: Wei-Jun Qian

Participating Institutions

News & Announcements

View all →